The PHC1 Gene Microcephaly Autosomal Recessive Type 11 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the PHC1 gene, which are implicated in Microcephaly Autosomal Recessive Type 11. This condition is characterized by significantly reduced head circumference, often accompanied by developmental delays and neurological issues, due to reduced brain size. The test is crucial for families with a history of the condition, aiming for early diagnosis and management strategies for affected individuals. The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic mutations associated with the disorder. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed genetic counseling that accompanies the results, guiding patients and families through the implications of the findings and potential next steps.
The CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the CDK6 gene, which are linked to Microcephaly Autosomal Recessive Type 12. This condition is characterized by significantly reduced head circumference evident at birth, reflecting an underdeveloped brain. Affected individuals may also experience developmental delays and other neurological issues. The test is crucial for confirming the diagnosis, understanding the disease progression, and guiding treatment and management decisions for affected individuals and their families.
This genetic test involves analyzing the patient's DNA to look for specific mutations in the CDK6 gene that are known to cause the disorder. Early diagnosis through genetic testing can be instrumental in managing the condition, allowing healthcare providers to offer timely interventions and support to improve the quality of life for those affected.
The test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the CDK6 Gene Microcephaly Autosomal Recessive Type 12 Genetic Test is 4400 AED. Given the complexity of the test and the specialized technology required, this price reflects the resources involved in providing accurate and reliable results. Patients and families considering this test are encouraged to discuss it with their healthcare provider to understand its benefits and implications fully.
The TUBA1A gene Lissencephaly Type 3 genetic test is a specialized diagnostic tool designed to identify mutations in the TUBA1A gene, which are associated with Lissencephaly Type 3, a rare neurological disorder. This condition is characterized by a smooth brain surface and underdeveloped brain folds and grooves, leading to severe intellectual and developmental issues. The test is crucial for early diagnosis and intervention, providing essential information for managing the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs cutting-edge technology to accurately detect the presence of specific mutations in the TUBA1A gene. The cost of the test is 4400 AED, reflecting the sophisticated nature of the analysis and the comprehensive insights it offers into the genetic underpinnings of Lissencephaly Type 3. By pinpointing the exact genetic alterations, this test enables healthcare providers to tailor treatment and support plans to the individual needs of each patient, improving outcomes and quality of life for those affected by this challenging condition.
The LAMB1 gene plays a crucial role in brain development, and mutations in this gene are associated with Lissencephaly Type 5, a rare genetic disorder characterized by abnormal brain formation. This condition leads to significant neurological impairments, including developmental delay, intellectual disability, and seizures. Early and accurate diagnosis through genetic testing is vital for the management and treatment of the condition.
DNA Labs UAE offers a comprehensive genetic test specifically targeting the LAMB1 gene to identify mutations linked to Lissencephaly Type 5. The test is meticulously designed to provide reliable results, aiding in the early detection and enabling healthcare providers to devise appropriate intervention strategies for affected individuals.
The cost of the LAMB1 Gene Lissencephaly Type 5 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the advanced molecular techniques and expert analysis required to ensure accurate diagnosis. By choosing this test, patients and their families can gain valuable insights into the genetic underpinnings of Lissencephaly Type 5, facilitating informed decisions about care and management.
The DCX Gene Lissencephaly X-Linked Type 1 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the DCX gene, which are linked to Lissencephaly X-Linked Type 1. Lissencephaly, meaning "smooth brain," is a rare, genetic brain malformation characterized by the absence of normal brain folds and grooves. This condition primarily affects males and can lead to severe intellectual disability, developmental delay, muscle spasticity, seizures, and other neurological problems.
The test is crucial for families seeking to understand the genetic basis of the condition, as it can provide definitive confirmation of the diagnosis. This is particularly important for genetic counseling, understanding the risk of recurrence in future pregnancies, and for tailoring appropriate therapeutic interventions and support for affected individuals.
Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE. The lab employs cutting-edge genetic sequencing technologies to identify mutations in the DCX gene, ensuring high accuracy and reliability of the results.
By opting for the DCX Gene Lissencephaly X-Linked Type 1 Genetic Test at DNA Labs UAE, families and individuals are taking a significant step towards understanding and managing this complex condition, armed with precise genetic information that can inform medical and personal decisions.
The ARX Gene Lissencephaly X-Linked Type 2 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the ARX gene, which are linked to Lissencephaly X-Linked Type 2, a rare genetic disorder. This condition is characterized by abnormal brain development that leads to smooth brain surfaces, intellectual disabilities, and seizures. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic changes associated with the disorder.
The importance of this test lies in its ability to provide crucial information for families affected by Lissencephaly X-Linked Type 2, facilitating early intervention, management plans, and genetic counseling. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test ensures accuracy, confidentiality, and support through the diagnostic process. The cost of the ARX Gene Lissencephaly X-Linked Type 2 Genetic Test is 4400 AED, reflecting the comprehensive analysis and expert interpretation provided to diagnose this complex condition accurately.
The MED12 Gene Lujan-Fryns Syndrome Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the MED12 gene, which are associated with Lujan-Fryns syndrome. This condition is a rare X-linked genetic disorder characterized by marfanoid habitus, intellectual disability, and distinctive facial features. The test plays a crucial role in the accurate diagnosis of the syndrome, enabling healthcare professionals to provide targeted interventions and support for affected individuals. Priced at 4400 AED, the test involves analyzing the patient's DNA to identify specific genetic alterations in the MED12 gene, providing insights into the presence of Lujan-Fryns syndrome. This testing is essential for families seeking to understand the genetic basis of the condition, potentially guiding decisions regarding management and treatment options. DNA Labs UAE, by offering this test, contributes significantly to the field of genetic diagnostics, facilitating early detection and improved outcomes for patients with this rare genetic disorder.
The FOXC2 gene lymphedema-distichiasis syndrome genetic test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the FOXC2 gene, which are linked to the development of lymphedema-distichiasis syndrome (LDS). LDS is a rare genetic disorder characterized by swelling (lymphedema) primarily in the legs, due to fluid accumulation, and distichiasis, the presence of extra eyelashes that may irritate the eye. This test is crucial for individuals who have a family history of LDS or exhibit symptoms of the condition, as early detection can lead to better management and treatment options.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any genetic variations in the FOXC2 gene that may be responsible for the syndrome. The cost of the test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. By confirming a diagnosis of lymphedema-distichiasis syndrome, affected individuals can seek appropriate medical interventions, such as physical therapy, surgery, or specialized eye care, to manage symptoms and improve quality of life.
The RIN2 gene macrocephaly alopecia cutis laxa and scoliosis genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the RIN2 gene. These mutations are associated with a rare genetic condition that manifests as a combination of symptoms including macrocephaly (an unusually large head), alopecia (hair loss), cutis laxa (loose and wrinkled skin), and scoliosis (curvature of the spine). This comprehensive test is crucial for individuals exhibiting these symptoms or those with a family history of the condition, as it aids in the accurate diagnosis and understanding of the genetic basis of their symptoms. The cost of the test is 4400 AED, reflecting the intricate processes involved in genetic analysis and the specialized expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, this test is a vital step towards personalized medical care, enabling targeted treatment and management plans for affected individuals.
The POLD1 Gene Mandibular Hypoplasia Deafness Progeroid Features and Lipodystrophy Syndrome Genetic Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the POLD1 gene. These mutations are associated with a rare genetic disorder characterized by a range of symptoms including mandibular hypoplasia (underdevelopment of the jaw), deafness, features of premature aging (progeroid features), and lipodystrophy (abnormal distribution of body fat). The test is crucial for accurate diagnosis, enabling targeted management and treatment strategies for affected individuals.
Performed using a sample of the patient's DNA, the test scrutinizes the POLD1 gene for specific mutations known to cause this syndrome. Given the complexity and the precision of the technology involved, the cost of the test is 4400 AED. Conducting the test at DNA Labs UAE ensures that patients and healthcare providers benefit from the expertise of a leading genetics laboratory, known for its advanced diagnostic capabilities and commitment to quality healthcare solutions. Early and accurate diagnosis through this genetic test can significantly improve the quality of life for individuals with this rare condition, by facilitating timely interventions and personalized care plans.
